Lord, Abbett & Co. LLC Amgen Inc Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 07, 2024	BUY	$229.03 - $291.01 $19.5 Million - $24.8 Million	85,250 New	85,250 $22.4 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $19.5 Million - $24.8 Million	85,250 New	85,250 $22.4 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $42.7 Million - $47.5 Million	-185,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $40.6 Million - $44.9 Million	185,000 New	185,000 $44.7 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $52.1 Million - $60.7 Million	-234,673 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $19.1 Million - $22.8 Million	-88,482 Reduced 27.38%	234,673 $54 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $994,916 - $1.11 Million	4,240 Added 1.33%	323,155 $82.1 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $13.3 Million - $16.3 Million	-67,352 Reduced 17.44%	318,915 $75.2 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $844,135 - $1.12 Million	-4,632 Reduced 1.18%	386,267 $78.3 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $25.7 Million - $33.1 Million	136,089 Added 53.41%	390,899 $94.2 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $3.95 Million - $4.73 Million	-22,680 Reduced 8.17%	254,810 $49.3 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $20.1 Million - $23.5 Million	120,490 Added 76.75%	277,490 $51.1 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $14.7 Million - $16.6 Million	-81,218 Reduced 34.09%	157,000 $29.8 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $7.98 Million - $9.32 Million	-44,736 Reduced 15.81%	238,218 $46.4 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $14.3 Million - $16.2 Million	-77,346 Reduced 21.47%	282,954 $58.7 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $9.27 Million - $10.4 Million	55,800 Added 18.33%	360,300 $66.5 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $1.25 Million - $1.47 Million	-7,400 Reduced 2.37%	304,500 $51.9 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $1.65 Million - $1.85 Million	-9,800 Reduced 3.05%	311,900 $54.2 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $40 Million - $45.7 Million	239,395 Added 290.86%	321,700 $60 Million
Q2 2017 Aug 14, 2017	BUY	N/A	82,305	82,305 $14.2 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account